ISPOR Madrid saw the first ever e-poster (electronic scientific poster) at the BaseCase booth where you could literally put your fingers on the evidence. This first e-poster was a huge success and visualized the highly interesting study Cost Savings and Improved Utility Through the Use of beta-Amyloid-Specific PET in Dementia Diagnosis provided by Bayer Healthcare Pharmaceuticals and Karolinska Institute.

BaseCase will be attending and sponsoring the 17th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). This year’s ISPOR will be held June 2nd- 6th at the Washington D.C. Hilton. The meeting will focus on three main topics: Comparing the Effectiveness of New Drugs, Health Reform in the US, and Performance-Based Risk-Sharing Arrangements.

Stop by the BaseCase booth #5, located at the concourse level across from registration, to see how our spreadsheet-based web apps communicate the comparative effectiveness of your products. BaseCase’s iPad-friendly apps run everywhere and now they can even be turned into a PDF and viewed from PowerPoint. Our apps also support detailed user-analytics so you can track the number of times your app is accessed, how long it is used in the field, and which reps are generating reports.

Test out one of our interactive budget-impact, cost-effectiveness, or patient eligibility apps and see how we visualize your data to best demonstrate your product’s value.

Want to discuss any of the mentioned tools or an upcoming project with us in detail? Send an email to info@basecase.com to book a face-to-face meeting and we can tailor a BaseCase solution to meet your needs.

Today’s blog post is courtesy of Dr. Maryna Zilberberg from Healthcare, etc.. We recently discovered her blog and found the following article to be especially relevant. The article explains how to use cost-effectiveness propositions to avoid several fallacies that interfere with decision-making in drug development.

Mobile devices have been key to the healthcare, pharmaceutical and medical device industries for decades and this year’s iPad 3 is no different. The iPad 3 was released to the United States and Europe about one month ago and will soon be available in 21 additional countries on April 20th. One of the main features, which will be very useful for visualizing health economic models, is the iPad 3’s retina display. This new feature enables the image, evidence, or whatever you are presenting to be rendered with extreme clarity. The retina display, in addition to the other newest features, will allow the iPad 3 to not only follow but improve upon the iPad’s previous successes in the healthcare, pharmaceutical and medical device industries.

‘Tweet us about your headache!’ Do you follow and interact with pharmaceutical companies on Twitter? These days everyone and their dog is on Twitter yet the pharmaceutical industry has mostly been reluctant to join.

Linked sliders are a set of sliders which are linked to sum up to 100% by default. Each time you change the value of one slider, the slider underneath it will be affected accordingly too. If you don’t want a particular slider to change anymore, you can simply click the small lock on the left to lock the current value.

If a picture is worth a thousand words – how many is an interactive presentation worth? Interactive presentations leverage the latest technology to enable pick-a-path type discussions in which audience members can participate and modify inputs with the slide of a button. Sales presentations usually contain generalized information as reps cannot foresee the customers’ exact requirements or needs. In contrast, interactive presentations become smarter during the pitch as they incorporate audiences’ personalized information to allow for more focused discussions. Interactive presentations upgrade the pitch from a monologue to a joint collaboration that results in faster purchasing decisions while eliminating multiple meetings.

We recently attended and presented at the 3rd Annual European Medical Device Conference in Brussels, Belgium on January 23rd and 24th, 2012. The conference focused on integration and setting a single pathway for the introduction of new products to the market and gaining reimbursement for these new products and existing offerings. Other specific topics included reimbursement of medical devices in European countries and how clinical data supports access to additional funding.

BaseCase welcomes OptumInsight as the latest member of our Solution Provider Program. OptumInsight is now fully certified to deliver content on the BaseCase Interactive platform.

Our latest trip to ISPOR Madrid prompted the editor at Health Economics Digest to mention us in the innovation section of his recent vidcast. We appreciate the link between our unique presentation platform and innovation in our industry. BaseCase’s first electronic poster (aka e-poster) showed attendees at ISPOR how our platform presents evidence “in a visually appealing way”. Look for us around 4:02 but don’t forget to enjoy the rest of the vidcast discussing other interesting topics, articles and links relevant to HEOR.

Thanks for the mention Duncan.